🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wei-Lin Jin

Peking University

ORCID: 0000-0001-8011-2405

Also affiliated with First Hospital of Lanzhou University, Lanzhou University

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A
0Author DataRank · unranked

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: B7-H3/CD276: An Emerging Cancer Immunotherapy.

N/A
6.8DataRank · unranked
295 citations

Wei-Lin Jin, Wu-Tong Zhou

Drug repurposing for cancer therapy

Signal Transduction and Targeted Therapy(2024)10.1038/s41392-024-01808-1
N/A
5.3DataRank · unranked
405 citations

Ming Sun, Hai Huang, Wei-Lin Jin, Ying Xia

N/A
0.292DataRank · unranked
6 citations

Pin Chen, Xiao-Yin Xu, Jia-Qi Zhang, Wei-Lin Jin, Wei Sun